The Nervous System Chemicals market encompasses a wide range of neurologic medications specifically designed to treat neurological disorders and disease symptoms. These disorders include Alzheimer’s disease, Parkinson’s disease, epilepsy, and migraines, among others. Nervous system chemicals function by targeting the central or peripheral nervous systems to alleviate symptoms, improve cognitive function, and enhance the quality of life for patients. These medications are available in both prescription and over-the-counter forms, catering to diverse patient needs and healthcare environments.
Market Size
The global Nervous System Chemicals market was valued at USD 80,020 million in 2023 and is projected to grow to USD 124,137.28 million by 2032, demonstrating a CAGR of 5.00% during the forecast period.
North America, a key market region, was estimated at USD 22,676.45 million in 2023 and is expected to maintain a steady growth trajectory with a CAGR of 4.29% from 2025 through 2032.
Historical trends reveal a robust increase in demand due to rising awareness of neurological disorders and advancements in pharmaceutical research. The aging population has further driven market growth, as conditions like Alzheimer’s and Parkinson’s are more prevalent in older demographics. Increasing healthcare spending and government initiatives to improve access to neurologic medications also contribute significantly to the market's expansion.
Key statistics highlight the scale of the market:
- Global CAGR (2023-2032): 5.00%
- North America’s share: 28.3% in 2023
- Asia-Pacific’s expected growth: Fastest at 6.5% CAGR
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers
-
Increasing Prevalence of Neurological Disorders: The rising global incidence of Alzheimer’s, epilepsy, and migraines is propelling the demand for effective treatment options.
-
Advancements in Pharmaceutical Research: Innovations in drug delivery systems, such as extended-release formulations and biologics, are driving market growth.
-
Growing Geriatric Population: The aging population is particularly susceptible to neurodegenerative diseases, fueling demand for neurologic medications.
-
Improved Healthcare Infrastructure: Investments in healthcare systems, particularly in emerging economies, have expanded the availability of nervous system chemicals.
Restraints
-
High Development Costs: The high costs associated with R&D and clinical trials for neurological drugs act as a barrier for new market entrants.
-
Regulatory Challenges: Strict FDA and EMA guidelines can delay the approval process for new medications.
-
Side Effects: Adverse effects associated with neurologic medications, such as drowsiness and dependency, can hinder market adoption.
Opportunities
-
Emerging Markets: The Asia-Pacific region, with its growing population and healthcare investments, offers significant growth opportunities.
-
Personalized Medicine: Advances in genetic research and precision medicine are enabling tailored treatments, opening new revenue streams.
-
Technological Integration: Use of AI in drug discovery is expected to reduce costs and accelerate development timelines.
Challenges
-
Competition from Generics: Patent expirations for blockbuster drugs result in increased competition from generic versions.
-
Patient Non-Adherence: Lack of compliance with prescribed medication regimens reduces treatment efficacy.
-
Ethical Concerns: Issues related to clinical trials and accessibility of high-cost medications remain significant challenges.
Regional Analysis
North America - North America dominates the global Nervous System Chemicals market, accounting for USD 22,676.45 million in 2023. The region’s growth is driven by advanced healthcare systems, high R&D investment, and a rising prevalence of neurological disorders. The U.S. contributes the largest share, with Canada and Mexico exhibiting steady growth.
Europe - Europe holds a significant market share, with Germany, the UK, and France leading in pharmaceutical production. Favorable reimbursement policies and increasing healthcare awareness contribute to the region’s steady growth.
Asia-Pacific - Asia-Pacific is the fastest-growing region, driven by rising healthcare investments in China, Japan, and India. Increasing disposable incomes and a growing aging population are key factors propelling market growth.
South America - Brazil and Argentina dominate the South American market. Despite slower growth compared to other regions, increasing investments in healthcare infrastructure are improving market prospects.
Middle East and Africa - The Middle East and Africa represent emerging markets with untapped potential. Countries like Saudi Arabia and South Africa are investing heavily in healthcare modernization, creating opportunities for nervous system chemical manufacturers.
Competitor Analysis (in brief)
The Nervous System Chemicals market is highly competitive, with key players focusing on R&D, strategic acquisitions, and product innovation to maintain their market positions. Leading companies include:
-
Pfizer: A market leader known for its extensive neurological drug portfolio.
-
Ely Lilly: Specializes in treatments for Alzheimer’s and migraine disorders.
-
AstraZeneca: Focuses on innovative solutions for neurological diseases.
-
Johnson & Johnson: Offers a diversified range of prescription and over-the-counter products.
-
Novartis: Known for pioneering research in neurological therapeutics.
Market Segmentation (by Application)
-
Hospital: Represents the largest application segment, with hospitals being primary providers of neurological treatments.
-
Clinic: Clinics cater to outpatients, making them an essential market segment.
-
Other: Includes home care settings and long-term care facilities.
Market Segmentation (by Type)
-
Non-Prescription Drugs: Includes over-the-counter medications for common neurological conditions like migraines.
-
Prescription Drugs: Encompasses medications for chronic and severe neurological disorders.
Key Company
The report highlights key players driving the market, including:
- Pfizer
- Ely Lilly
- Actavis (Teva Pharmaceuticals)
- Mylan (Viatris)
- UCB
- AstraZeneca
- Johnson & Johnson
- Novartis
Geographic Segmentation
- North America: USA, Canada, Mexico
- Europe: Germany, UK, France, Russia, Italy, Rest of Europe
- Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
- South America: Brazil, Argentina, Columbia, Rest of South America
- Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
FAQ Section
1. What is the current market size of the Nervous System Chemicals market?
The global market size was valued at USD 80,020 million in 2023 and is projected to reach USD 124,137.28 million by 2032.
2. Which are the key companies operating in the Nervous System Chemicals market?
Leading players include Pfizer, Ely Lilly, AstraZeneca, Novartis, and Johnson & Johnson.
3. What are the key growth drivers in the Nervous System Chemicals market?
Key drivers include the increasing prevalence of neurological disorders, advancements in pharmaceutical research, and a growing geriatric population.
4. Which regions dominate the Nervous System Chemicals market?
North America holds the largest market share, followed by Europe and the Asia-Pacific region.
5. What are the emerging trends in the Nervous System Chemicals market?
Emerging trends include the adoption of personalized medicine, increased use of AI in drug discovery, and expansion into emerging markets like Asia-Pacific and Africa.
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nervous System Chemicals Market
- Overview of the regional outlook of the Nervous System Chemicals Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nervous System Chemicals
1.2 Key Market Segments
1.2.1 Nervous System Chemicals Segment by Type
1.2.2 Nervous System Chemicals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nervous System Chemicals Market Overview
2.1 Global Market Overview
2.1.1 Global Nervous System Chemicals Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Nervous System Chemicals Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nervous System Chemicals Market Competitive Landscape
3.1 Global Nervous System Chemicals Sales by Manufacturers (2019-2025)
3.2 Global Nervous System Chemicals Revenue Market Share by Manufacturers (2019-2025)
3.3 Nervous System Chemicals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nervous System Chemicals Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Nervous System Chemicals Sales Sites, Area Served, Product Type
3.6 Nervous System Chemicals Market Competitive Situation and Trends
3.6.1 Nervous System Chemicals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nervous System Chemicals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nervous System Chemicals Industry Chain Analysis
4.1 Nervous System Chemicals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nervous System Chemicals Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nervous System Chemicals Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nervous System Chemicals Sales Market Share by Type (2019-2025)
6.3 Global Nervous System Chemicals Market Size Market Share by Type (2019-2025)
6.4 Global Nervous System Chemicals Price by Type (2019-2025)
7 Nervous System Chemicals Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nervous System Chemicals Market Sales by Application (2019-2025)
7.3 Global Nervous System Chemicals Market Size (M USD) by Application (2019-2025)
7.4 Global Nervous System Chemicals Sales Growth Rate by Application (2019-2025)
8 Nervous System Chemicals Market Consumption by Region
8.1 Global Nervous System Chemicals Sales by Region
8.1.1 Global Nervous System Chemicals Sales by Region
8.1.2 Global Nervous System Chemicals Sales Market Share by Region
8.2 North America
8.2.1 North America Nervous System Chemicals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nervous System Chemicals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nervous System Chemicals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nervous System Chemicals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nervous System Chemicals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Nervous System Chemicals Market Production by Region
9.1 Global Production of Nervous System Chemicals by Region (2019-2025)
9.2 Global Nervous System Chemicals Revenue Market Share by Region (2019-2025)
9.3 Global Nervous System Chemicals Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Nervous System Chemicals Production
9.4.1 North America Nervous System Chemicals Production Growth Rate (2019-2025)
9.4.2 North America Nervous System Chemicals Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Nervous System Chemicals Production
9.5.1 Europe Nervous System Chemicals Production Growth Rate (2019-2025)
9.5.2 Europe Nervous System Chemicals Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Nervous System Chemicals Production (2019-2025)
9.6.1 Japan Nervous System Chemicals Production Growth Rate (2019-2025)
9.6.2 Japan Nervous System Chemicals Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Nervous System Chemicals Production (2019-2025)
9.7.1 China Nervous System Chemicals Production Growth Rate (2019-2025)
9.7.2 China Nervous System Chemicals Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pfizer
10.1.1 Pfizer Nervous System Chemicals Basic Information
10.1.2 Pfizer Nervous System Chemicals Product Overview
10.1.3 Pfizer Nervous System Chemicals Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Nervous System Chemicals SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Ely Lilly
10.2.1 Ely Lilly Nervous System Chemicals Basic Information
10.2.2 Ely Lilly Nervous System Chemicals Product Overview
10.2.3 Ely Lilly Nervous System Chemicals Product Market Performance
10.2.4 Ely Lilly Business Overview
10.2.5 Ely Lilly Nervous System Chemicals SWOT Analysis
10.2.6 Ely Lilly Recent Developments
10.3 Actavis(Teva Pharmaceuticals)
10.3.1 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Basic Information
10.3.2 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product Overview
10.3.3 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product Market Performance
10.3.4 Actavis(Teva Pharmaceuticals) Nervous System Chemicals SWOT Analysis
10.3.5 Actavis(Teva Pharmaceuticals) Business Overview
10.3.6 Actavis(Teva Pharmaceuticals) Recent Developments
10.4 Mylan(Viatris)
10.4.1 Mylan(Viatris) Nervous System Chemicals Basic Information
10.4.2 Mylan(Viatris) Nervous System Chemicals Product Overview
10.4.3 Mylan(Viatris) Nervous System Chemicals Product Market Performance
10.4.4 Mylan(Viatris) Business Overview
10.4.5 Mylan(Viatris) Recent Developments
10.5 UCB
10.5.1 UCB Nervous System Chemicals Basic Information
10.5.2 UCB Nervous System Chemicals Product Overview
10.5.3 UCB Nervous System Chemicals Product Market Performance
10.5.4 UCB Business Overview
10.5.5 UCB Recent Developments
10.6 Intellipharmaceutics
10.6.1 Intellipharmaceutics Nervous System Chemicals Basic Information
10.6.2 Intellipharmaceutics Nervous System Chemicals Product Overview
10.6.3 Intellipharmaceutics Nervous System Chemicals Product Market Performance
10.6.4 Intellipharmaceutics Business Overview
10.6.5 Intellipharmaceutics Recent Developments
10.7 Astrazeneca
10.7.1 Astrazeneca Nervous System Chemicals Basic Information
10.7.2 Astrazeneca Nervous System Chemicals Product Overview
10.7.3 Astrazeneca Nervous System Chemicals Product Market Performance
10.7.4 Astrazeneca Business Overview
10.7.5 Astrazeneca Recent Developments
10.8 Lundbeck
10.8.1 Lundbeck Nervous System Chemicals Basic Information
10.8.2 Lundbeck Nervous System Chemicals Product Overview
10.8.3 Lundbeck Nervous System Chemicals Product Market Performance
10.8.4 Lundbeck Business Overview
10.8.5 Lundbeck Recent Developments
10.9 Allergan(AbbVie)
10.9.1 Allergan(AbbVie) Nervous System Chemicals Basic Information
10.9.2 Allergan(AbbVie) Nervous System Chemicals Product Overview
10.9.3 Allergan(AbbVie) Nervous System Chemicals Product Market Performance
10.9.4 Allergan(AbbVie) Business Overview
10.9.5 Allergan(AbbVie) Recent Developments
10.10 GSK
10.10.1 GSK Nervous System Chemicals Basic Information
10.10.2 GSK Nervous System Chemicals Product Overview
10.10.3 GSK Nervous System Chemicals Product Market Performance
10.10.4 GSK Business Overview
10.10.5 GSK Recent Developments
10.11 Otsuka Pharmaceutical
10.11.1 Otsuka Pharmaceutical Nervous System Chemicals Basic Information
10.11.2 Otsuka Pharmaceutical Nervous System Chemicals Product Overview
10.11.3 Otsuka Pharmaceutical Nervous System Chemicals Product Market Performance
10.11.4 Otsuka Pharmaceutical Business Overview
10.11.5 Otsuka Pharmaceutical Recent Developments
10.12 Takeda
10.12.1 Takeda Nervous System Chemicals Basic Information
10.12.2 Takeda Nervous System Chemicals Product Overview
10.12.3 Takeda Nervous System Chemicals Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
10.13 Novartis
10.13.1 Novartis Nervous System Chemicals Basic Information
10.13.2 Novartis Nervous System Chemicals Product Overview
10.13.3 Novartis Nervous System Chemicals Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Johnson and Johnson
10.14.1 Johnson and Johnson Nervous System Chemicals Basic Information
10.14.2 Johnson and Johnson Nervous System Chemicals Product Overview
10.14.3 Johnson and Johnson Nervous System Chemicals Product Market Performance
10.14.4 Johnson and Johnson Business Overview
10.14.5 Johnson and Johnson Recent Developments
10.15 Eisai
10.15.1 Eisai Nervous System Chemicals Basic Information
10.15.2 Eisai Nervous System Chemicals Product Overview
10.15.3 Eisai Nervous System Chemicals Product Market Performance
10.15.4 Eisai Business Overview
10.15.5 Eisai Recent Developments
10.16 Kelun Pharmaceutical
10.16.1 Kelun Pharmaceutical Nervous System Chemicals Basic Information
10.16.2 Kelun Pharmaceutical Nervous System Chemicals Product Overview
10.16.3 Kelun Pharmaceutical Nervous System Chemicals Product Market Performance
10.16.4 Kelun Pharmaceutical Business Overview
10.16.5 Kelun Pharmaceutical Recent Developments
10.17 Humanwell Pharmaceutical
10.17.1 Humanwell Pharmaceutical Nervous System Chemicals Basic Information
10.17.2 Humanwell Pharmaceutical Nervous System Chemicals Product Overview
10.17.3 Humanwell Pharmaceutical Nervous System Chemicals Product Market Performance
10.17.4 Humanwell Pharmaceutical Business Overview
10.17.5 Humanwell Pharmaceutical Recent Developments
10.18 Enhua Pharmaceutical
10.18.1 Enhua Pharmaceutical Nervous System Chemicals Basic Information
10.18.2 Enhua Pharmaceutical Nervous System Chemicals Product Overview
10.18.3 Enhua Pharmaceutical Nervous System Chemicals Product Market Performance
10.18.4 Enhua Pharmaceutical Business Overview
10.18.5 Enhua Pharmaceutical Recent Developments
10.19 Yangzijiang Pharmaceutical
10.19.1 Yangzijiang Pharmaceutical Nervous System Chemicals Basic Information
10.19.2 Yangzijiang Pharmaceutical Nervous System Chemicals Product Overview
10.19.3 Yangzijiang Pharmaceutical Nervous System Chemicals Product Market Performance
10.19.4 Yangzijiang Pharmaceutical Business Overview
10.19.5 Yangzijiang Pharmaceutical Recent Developments
11 Nervous System Chemicals Market Forecast by Region
11.1 Global Nervous System Chemicals Market Size Forecast
11.2 Global Nervous System Chemicals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nervous System Chemicals Market Size Forecast by Country
11.2.3 Asia Pacific Nervous System Chemicals Market Size Forecast by Region
11.2.4 South America Nervous System Chemicals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Nervous System Chemicals by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Nervous System Chemicals Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Nervous System Chemicals by Type (2025-2032)
12.1.2 Global Nervous System Chemicals Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Nervous System Chemicals by Type (2025-2032)
12.2 Global Nervous System Chemicals Market Forecast by Application (2025-2032)
12.2.1 Global Nervous System Chemicals Sales (K MT) Forecast by Application
12.2.2 Global Nervous System Chemicals Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nervous System Chemicals Market Size Comparison by Region (M USD)
Table 5. Global Nervous System Chemicals Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Nervous System Chemicals Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Nervous System Chemicals Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Nervous System Chemicals Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Chemicals as of 2022)
Table 10. Global Market Nervous System Chemicals Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Nervous System Chemicals Sales Sites and Area Served
Table 12. Manufacturers Nervous System Chemicals Product Type
Table 13. Global Nervous System Chemicals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nervous System Chemicals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nervous System Chemicals Market Challenges
Table 22. Global Nervous System Chemicals Sales by Type (K MT)
Table 23. Global Nervous System Chemicals Market Size by Type (M USD)
Table 24. Global Nervous System Chemicals Sales (K MT) by Type (2019-2025)
Table 25. Global Nervous System Chemicals Sales Market Share by Type (2019-2025)
Table 26. Global Nervous System Chemicals Market Size (M USD) by Type (2019-2025)
Table 27. Global Nervous System Chemicals Market Size Share by Type (2019-2025)
Table 28. Global Nervous System Chemicals Price (USD/MT) by Type (2019-2025)
Table 29. Global Nervous System Chemicals Sales (K MT) by Application
Table 30. Global Nervous System Chemicals Market Size by Application
Table 31. Global Nervous System Chemicals Sales by Application (2019-2025) & (K MT)
Table 32. Global Nervous System Chemicals Sales Market Share by Application (2019-2025)
Table 33. Global Nervous System Chemicals Sales by Application (2019-2025) & (M USD)
Table 34. Global Nervous System Chemicals Market Share by Application (2019-2025)
Table 35. Global Nervous System Chemicals Sales Growth Rate by Application (2019-2025)
Table 36. Global Nervous System Chemicals Sales by Region (2019-2025) & (K MT)
Table 37. Global Nervous System Chemicals Sales Market Share by Region (2019-2025)
Table 38. North America Nervous System Chemicals Sales by Country (2019-2025) & (K MT)
Table 39. Europe Nervous System Chemicals Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Nervous System Chemicals Sales by Region (2019-2025) & (K MT)
Table 41. South America Nervous System Chemicals Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Nervous System Chemicals Sales by Region (2019-2025) & (K MT)
Table 43. Global Nervous System Chemicals Production (K MT) by Region (2019-2025)
Table 44. Global Nervous System Chemicals Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Nervous System Chemicals Revenue Market Share by Region (2019-2025)
Table 46. Global Nervous System Chemicals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Nervous System Chemicals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Nervous System Chemicals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Nervous System Chemicals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Nervous System Chemicals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Pfizer Nervous System Chemicals Basic Information
Table 52. Pfizer Nervous System Chemicals Product Overview
Table 53. Pfizer Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Pfizer Business Overview
Table 55. Pfizer Nervous System Chemicals SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Ely Lilly Nervous System Chemicals Basic Information
Table 58. Ely Lilly Nervous System Chemicals Product Overview
Table 59. Ely Lilly Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Ely Lilly Business Overview
Table 61. Ely Lilly Nervous System Chemicals SWOT Analysis
Table 62. Ely Lilly Recent Developments
Table 63. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Basic Information
Table 64. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product Overview
Table 65. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Actavis(Teva Pharmaceuticals) Nervous System Chemicals SWOT Analysis
Table 67. Actavis(Teva Pharmaceuticals) Business Overview
Table 68. Actavis(Teva Pharmaceuticals) Recent Developments
Table 69. Mylan(Viatris) Nervous System Chemicals Basic Information
Table 70. Mylan(Viatris) Nervous System Chemicals Product Overview
Table 71. Mylan(Viatris) Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Mylan(Viatris) Business Overview
Table 73. Mylan(Viatris) Recent Developments
Table 74. UCB Nervous System Chemicals Basic Information
Table 75. UCB Nervous System Chemicals Product Overview
Table 76. UCB Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. UCB Business Overview
Table 78. UCB Recent Developments
Table 79. Intellipharmaceutics Nervous System Chemicals Basic Information
Table 80. Intellipharmaceutics Nervous System Chemicals Product Overview
Table 81. Intellipharmaceutics Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Intellipharmaceutics Business Overview
Table 83. Intellipharmaceutics Recent Developments
Table 84. Astrazeneca Nervous System Chemicals Basic Information
Table 85. Astrazeneca Nervous System Chemicals Product Overview
Table 86. Astrazeneca Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Astrazeneca Business Overview
Table 88. Astrazeneca Recent Developments
Table 89. Lundbeck Nervous System Chemicals Basic Information
Table 90. Lundbeck Nervous System Chemicals Product Overview
Table 91. Lundbeck Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Lundbeck Business Overview
Table 93. Lundbeck Recent Developments
Table 94. Allergan(AbbVie) Nervous System Chemicals Basic Information
Table 95. Allergan(AbbVie) Nervous System Chemicals Product Overview
Table 96. Allergan(AbbVie) Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Allergan(AbbVie) Business Overview
Table 98. Allergan(AbbVie) Recent Developments
Table 99. GSK Nervous System Chemicals Basic Information
Table 100. GSK Nervous System Chemicals Product Overview
Table 101. GSK Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. GSK Business Overview
Table 103. GSK Recent Developments
Table 104. Otsuka Pharmaceutical Nervous System Chemicals Basic Information
Table 105. Otsuka Pharmaceutical Nervous System Chemicals Product Overview
Table 106. Otsuka Pharmaceutical Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Otsuka Pharmaceutical Business Overview
Table 108. Otsuka Pharmaceutical Recent Developments
Table 109. Takeda Nervous System Chemicals Basic Information
Table 110. Takeda Nervous System Chemicals Product Overview
Table 111. Takeda Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Takeda Business Overview
Table 113. Takeda Recent Developments
Table 114. Novartis Nervous System Chemicals Basic Information
Table 115. Novartis Nervous System Chemicals Product Overview
Table 116. Novartis Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Novartis Business Overview
Table 118. Novartis Recent Developments
Table 119. Johnson and Johnson Nervous System Chemicals Basic Information
Table 120. Johnson and Johnson Nervous System Chemicals Product Overview
Table 121. Johnson and Johnson Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Johnson and Johnson Business Overview
Table 123. Johnson and Johnson Recent Developments
Table 124. Eisai Nervous System Chemicals Basic Information
Table 125. Eisai Nervous System Chemicals Product Overview
Table 126. Eisai Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Eisai Business Overview
Table 128. Eisai Recent Developments
Table 129. Kelun Pharmaceutical Nervous System Chemicals Basic Information
Table 130. Kelun Pharmaceutical Nervous System Chemicals Product Overview
Table 131. Kelun Pharmaceutical Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Kelun Pharmaceutical Business Overview
Table 133. Kelun Pharmaceutical Recent Developments
Table 134. Humanwell Pharmaceutical Nervous System Chemicals Basic Information
Table 135. Humanwell Pharmaceutical Nervous System Chemicals Product Overview
Table 136. Humanwell Pharmaceutical Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Humanwell Pharmaceutical Business Overview
Table 138. Humanwell Pharmaceutical Recent Developments
Table 139. Enhua Pharmaceutical Nervous System Chemicals Basic Information
Table 140. Enhua Pharmaceutical Nervous System Chemicals Product Overview
Table 141. Enhua Pharmaceutical Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Enhua Pharmaceutical Business Overview
Table 143. Enhua Pharmaceutical Recent Developments
Table 144. Yangzijiang Pharmaceutical Nervous System Chemicals Basic Information
Table 145. Yangzijiang Pharmaceutical Nervous System Chemicals Product Overview
Table 146. Yangzijiang Pharmaceutical Nervous System Chemicals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Yangzijiang Pharmaceutical Business Overview
Table 148. Yangzijiang Pharmaceutical Recent Developments
Table 149. Global Nervous System Chemicals Sales Forecast by Region (2025-2032) & (K MT)
Table 150. Global Nervous System Chemicals Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America Nervous System Chemicals Sales Forecast by Country (2025-2032) & (K MT)
Table 152. North America Nervous System Chemicals Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe Nervous System Chemicals Sales Forecast by Country (2025-2032) & (K MT)
Table 154. Europe Nervous System Chemicals Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific Nervous System Chemicals Sales Forecast by Region (2025-2032) & (K MT)
Table 156. Asia Pacific Nervous System Chemicals Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America Nervous System Chemicals Sales Forecast by Country (2025-2032) & (K MT)
Table 158. South America Nervous System Chemicals Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa Nervous System Chemicals Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa Nervous System Chemicals Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global Nervous System Chemicals Sales Forecast by Type (2025-2032) & (K MT)
Table 162. Global Nervous System Chemicals Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global Nervous System Chemicals Price Forecast by Type (2025-2032) & (USD/MT)
Table 164. Global Nervous System Chemicals Sales (K MT) Forecast by Application (2025-2032)
Table 165. Global Nervous System Chemicals Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Nervous System Chemicals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nervous System Chemicals Market Size (M USD), 2019-2032
Figure 5. Global Nervous System Chemicals Market Size (M USD) (2019-2032)
Figure 6. Global Nervous System Chemicals Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nervous System Chemicals Market Size by Country (M USD)
Figure 11. Nervous System Chemicals Sales Share by Manufacturers in 2023
Figure 12. Global Nervous System Chemicals Revenue Share by Manufacturers in 2023
Figure 13. Nervous System Chemicals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nervous System Chemicals Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nervous System Chemicals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nervous System Chemicals Market Share by Type
Figure 18. Sales Market Share of Nervous System Chemicals by Type (2019-2025)
Figure 19. Sales Market Share of Nervous System Chemicals by Type in 2023
Figure 20. Market Size Share of Nervous System Chemicals by Type (2019-2025)
Figure 21. Market Size Market Share of Nervous System Chemicals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nervous System Chemicals Market Share by Application
Figure 24. Global Nervous System Chemicals Sales Market Share by Application (2019-2025)
Figure 25. Global Nervous System Chemicals Sales Market Share by Application in 2023
Figure 26. Global Nervous System Chemicals Market Share by Application (2019-2025)
Figure 27. Global Nervous System Chemicals Market Share by Application in 2023
Figure 28. Global Nervous System Chemicals Sales Growth Rate by Application (2019-2025)
Figure 29. Global Nervous System Chemicals Sales Market Share by Region (2019-2025)
Figure 30. North America Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Nervous System Chemicals Sales Market Share by Country in 2023
Figure 32. U.S. Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Nervous System Chemicals Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Nervous System Chemicals Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Nervous System Chemicals Sales Market Share by Country in 2023
Figure 37. Germany Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Nervous System Chemicals Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Nervous System Chemicals Sales Market Share by Region in 2023
Figure 44. China Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Nervous System Chemicals Sales and Growth Rate (K MT)
Figure 50. South America Nervous System Chemicals Sales Market Share by Country in 2023
Figure 51. Brazil Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Nervous System Chemicals Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Nervous System Chemicals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Nervous System Chemicals Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Nervous System Chemicals Production Market Share by Region (2019-2025)
Figure 62. North America Nervous System Chemicals Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Nervous System Chemicals Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Nervous System Chemicals Production (K MT) Growth Rate (2019-2025)
Figure 65. China Nervous System Chemicals Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Nervous System Chemicals Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Nervous System Chemicals Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Nervous System Chemicals Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Nervous System Chemicals Market Share Forecast by Type (2025-2032)
Figure 70. Global Nervous System Chemicals Sales Forecast by Application (2025-2032)
Figure 71. Global Nervous System Chemicals Market Share Forecast by Application (2025-2032)
